Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2012
07/26/2012US20120190821 Recombinant soluble fc receptors
07/26/2012US20120190815 Azacyclohexapeptide or its pharmaceutical acceptable salt, preparing method and use thereof
07/26/2012US20120190753 Compositions Containing Aromatic Aldehydes and Their Use in Treatments
07/26/2012US20120190739 Ep2 and ep4 agonists as agents for the treatment of influenza a viral infection
07/26/2012US20120190734 Compounds and compositions for treating infection
07/26/2012US20120190730 Targeting cells with altered microrna expression
07/26/2012US20120190723 Viral modulators and processes thereof
07/26/2012US20120190715 Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
07/26/2012US20120190713 Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
07/26/2012US20120190708 Targeting nad biosynthesis in bacterial pathogens
07/26/2012US20120190699 Pyridones useful as inhibitors of kinases
07/26/2012US20120190697 Hiv inhibiting bicyclic pyrimidine derivatives
07/26/2012US20120190676 Inhibitors of mtor kinase as anti-viral agents
07/26/2012US20120190664 Process for the preparation of antibiotic compounds
07/26/2012US20120190663 Use of free dna as an early predictor of severity in acute pancreatitis
07/26/2012US20120190661 Androgen composition for treating an opthalmic condition
07/26/2012US20120190651 Anti-inflammatory compounds
07/26/2012US20120190649 Bicyclic aryl sphingosine 1-phosphate analogs
07/26/2012US20120190637 Combination therapy treatment for viral infections
07/26/2012US20120190636 Composition for prophylaxis or treatment of urinary system infection and method thereof
07/26/2012US20120190635 Selective oxidation of c-h bonds of modified substrates by p450 monooxygenase
07/26/2012US20120190634 Lipoteichoic acid-derived glycolipids, and compositions comprising same
07/26/2012US20120190632 Anti-bacterial infection, inflammation, and leukemia composition and use thereof
07/26/2012US20120190614 Hcv protease inhibitors and uses thereof
07/26/2012US20120190613 Echinocandin derivatives
07/26/2012US20120190610 Tetranectin-apolipoprotein a-i, lipid particles containing it and its use
07/26/2012US20120189719 Schisandrae fructus extracts for inhibition or prevention of h1n1 influenza virus infection and its application thereof
07/26/2012US20120189718 Medicine for dissolving and eliminating wart and excrescence consisting of protein and its uses
07/26/2012US20120189717 Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting
07/26/2012US20120189716 Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting
07/26/2012US20120189715 Compositions including beta-hydroxy-beta-methylbutyrate and uses thereof
07/26/2012US20120189714 Compositions including beta-hydroxy-beta-methylbutyrate
07/26/2012US20120189711 Modular Extracorporeal Systems and Methods for Treating Blood-Borne Diseases
07/26/2012US20120189710 Antibacterial compositions
07/26/2012US20120189706 Macrocystis Pyrifera Derived Health and Wellness Products and Methods of Using the Same
07/26/2012US20120189693 Oral dosage forms
07/26/2012US20120189691 Drug carrier and drug carrier kit for inhibiting fibrosis
07/26/2012US20120189689 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
07/26/2012US20120189688 Carrier component and fabrication method thereof
07/26/2012US20120189685 Wound dressing comprising an anti-inflammatory pain-killing agent and a complex of silver ion and a transitional element of group iv of the periodic system of elements
07/26/2012US20120189684 Skincare Compositions
07/26/2012US20120189682 Inhibition of biofilm organisms
07/26/2012US20120189679 Method for coating powders
07/26/2012US20120189674 Compositions for topical delivery of the pharmacologically active compounds
07/26/2012US20120189673 Polypeptides and uses thereof
07/26/2012US20120189671 Absorbable Implants and Methods for their use in Hemostasis
07/26/2012US20120189669 Solid Forms for Tissue Repair
07/26/2012US20120189662 Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti
07/26/2012US20120189661 Vaccines comprising heat-sensitive transgenes
07/26/2012US20120189660 Composition for Preventing or Treating Liver Diseases, Containing Plant Stem Cell Lines Derived from the Cambium of Panax Ginseng Including Mountain Ginseng or Ginseng as Active Ingredient
07/26/2012US20120189658 Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin
07/26/2012US20120189657 Microbial vaccine and vaccine vector
07/26/2012US20120189655 Attenuated Live Vaccine for Prevention of Porcine Reproductive and Respiratory Syndrome
07/26/2012US20120189654 Vaccine
07/26/2012US20120189650 Immunogenic composition comprising variants of staphylococcal clumping factor a
07/26/2012US20120189649 Vaccines and Compositions Against Streptococcus Pneumoniae
07/26/2012US20120189648 Infectious hepatitis c viruses of genotype 3a and 4a and uses thereof
07/26/2012US20120189647 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
07/26/2012US20120189646 Novel compounds
07/26/2012US20120189645 Compositions and methods to treat and control tumors
07/26/2012US20120189642 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
07/26/2012US20120189639 Anti-gitr antibodies
07/26/2012US20120189626 Treatment of complement-associated disorders
07/26/2012US20120189615 CROSS-ß STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS-ß STRUCTURE, FOR MODULATING CROSS-ß STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS-ß STRUCTURE-MEDIATED TOXICITY
07/26/2012US20120189614 Inhibitors of filovirus entry into host cells
07/26/2012US20120189609 Improvement to trabeculectomy
07/26/2012US20120189608 New endolysin obpgplys
07/26/2012US20120189606 Antimicrobial Agents
07/26/2012US20120189588 Compositions and Methods for Implantation of Processed Adipose Tissue and Processed Adipose Tissue Products
07/26/2012US20120189583 Placental or umbilical cord tissue compositions
07/26/2012US20120189581 Use of toxoplasma and derived compositions to prevent or treat microbial infections
07/26/2012US20120189580 Anti-infective agents and uses thereof
07/26/2012US20120189579 Substituted pyrrolidinone as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use
07/26/2012US20120189568 Antimicrobial amino-salicylic acid derivatives
07/26/2012US20120189567 Artemisinin Derivatives with Natural Amino Acids, Peptides, and Amino Sugars for Skin Imperfections and Infection in Mammals
07/26/2012US20120189558 Anti-bacterial compositions comprising extracts of eremophila longifolia and methods for use of same
07/26/2012US20120189555 Methods and compositions for prevention or treatment of rsv infection
07/26/2012US20120189541 Dual Variable Domain Immunnoglobulins and Uses Thereof
07/26/2012US20120189537 Nitrile derivatives and their pharmaceutical use and compositions
07/26/2012US20120189493 Anti-microbial systems and methods
07/25/2012EP2479270A1 Gene expressing a bifidobacterium surface-presented fusion protein
07/25/2012EP2478103A2 Lassa virus-like particles and methods of production thereof
07/25/2012EP2477993A1 Substituted clavulanic acid
07/25/2012EP2477989A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY
07/25/2012EP2477987A1 Modulators of toll-like receptors
07/25/2012EP2477980A1 Hcv protease inhibitors
07/25/2012EP2477658A2 Hiv-1 antibodies
07/25/2012EP2477649A1 Vaccine against cholera and enterotoxigenic e. coli (etec) diarrhea
07/25/2012EP2220091B1 Reverse transcriptase inhibitors
07/25/2012EP2118110B1 Cyclopropyl fused indolobenzazepine hcv inhibitors
07/25/2012EP1711531B9 Neutralizing anti tlr4/md-2 antibodies and methods of use thereof
07/25/2012EP1558276B1 Flaviviris fusion inhibitors
07/25/2012EP1501921B2 Improved viral purification methods
07/25/2012EP1423701B1 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
07/25/2012EP1333808B1 Electroprocessed composition used in drug delivery and cell encapsulation
07/25/2012EP1322641B1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
07/25/2012EP1252162B1 Alpha v integrin receptor antagonists
07/25/2012EP1080111B1 The induction of antiobiotic peptides by lait (scd14) protein
07/25/2012CN1653183B Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
07/25/2012CN102612559A Modified peptide vaccine derived from influenza m2
1 ... 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 ... 1798